Wei Xue

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Venues

The Prostate

BMC urology

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Shaowei Xie, Xiaochen Fei, Jiayi Wang, Yi-Cheng Zhu, Jiazhou Liu, Xinxing Du, Xuesong Liu, Liang Dong, Yinjie Zhu, Jiahua Pan, Baijun Dong, Jianjun Sha, Yu Luo, Wenshe Sun, Wei Xue
Engineering the MoS 2 /MXene Heterostructure for Precise and Noninvasive Diagnosis of Prostate Cancer with Clinical Specimens. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Xiaochen Fei, Liancheng Fan, Wei Chen, Wei Chen, Yiming Gong, Xinxing Du, Yanqing Wang, Yinjie Zhu, Jiahua Pan, Fangqin Wang, Wanbing Zhao, Tongtong Liu, Yining Yang, Baijun Dong, Wei Xue
The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real-world multicenter study. Clinical and translational medicine 11 (10) (2022)
Yan Wang, Guangyu Wu, Liancheng Fan, Jiahua Pan, Yiming Gong, Xiaochen Fei, Xinxing Du, Yinjie Zhu, Wei Xue
The prognostic nomogram including MRI for locally advanced prostate cancer treated by radical prostatectomy. The Prostate 81 (8) (2021)
Liancheng Fan, Yan Yang, Chenfei Chi, Xiaowei Ma, Rui Wang, Yiming Gong, Hongying Zheng, Jiahua Pan, Yinjie Zhu, Baijun Dong, Wei Xue
Neuroendocrine differentiation markers guide treatment sequence selection in metastatic castration-resistant prostate cancer. The Prostate 79 (6) (2019)
Liancheng Fan, Baijun Dong, Chenfei Chi, Yanqing Wang, Yiming Gong, Jianjun Sha, Jiahua Pan, Xun Shangguan, Yiran Huang, Lixin Zhou, Wei Xue
Abiraterone acetate for chemotherapy-naive metastatic castration-resistant prostate cancer: a single-centre prospective study of efficacy, safety, and prognostic factors. BMC urology 18 (1) (2018)
Liancheng Fan, Rui Wang, Chenfei Chi, Wen Cai, Yong Zhang, Hongyang Qian, Xiaoguang Shao, Yanqing Wang, Fan Xu, Jiahua Pan, Yinjie Zhu, Xun Shangguan, Lixin Zhou, Baijun Dong, Wei Xue
Systemic immune-inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration-resistant prostate cancer patients. The Prostate 78 (4) (2017)
Baijun Dong, Liancheng Fan, Yanqing Wang, Chenfei Chi, Xiaowei Ma, Rui Wang, Wen Cai, Xiaoguang Shao, Jiahua Pan, Yinjie Zhu, Xun Shangguan, Zhixiang Xin, Jianian Hu, Shaowei Xie, Xiaonan Kang, Lixin Zhou, Wei Xue
Influence of abiraterone acetate on neuroendocrine differentiation in chemotherapy-naive metastatic castration-resistant prostate cancer. The Prostate 77 (13) (2017)
Liancheng Fan, Xiao Wang, Chenfei Chi, Yanqing Wang, Wen Cai, Xiaoguang Shao, Fan Xu, Jiahua Pan, Yinjie Zhu, Xun Shangguan, Zhixiang Xin, Jianian Hu, Shaowei Xie, Rui Wang, Lixin Zhou, Baijun Dong, Wei Xue
Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration-resistant prostate cancer patients treated with abiraterone. The Prostate 77 (12) (2017)

Wei Xue.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Wei Xue